[29P] Testing, property and stability of medicinal formulation,Novel formulations/Development of novel medicines and formulations/Dispensing, prescription audit and ordering,Drug management,Risk management/Formulation testing・In-house formulation・Management of intravenous and enteral nutrition/Others

8:30 AM - 3:00 PM JST(11:30 PM - 6:00 AM UTC)

[29PA-371S] Current situation and issues of contraindication descriptions for patients with renal impairment in pharmaceutical package Inserts: A survey based on the new Labeling guidelines

○Momo Watanabe¹, Masahiro Kobayashi^1,2, Tatsuya Okuwaki², Sumika Nara¹, Mika Maeda^1,2, Katsuya Otori^1,2 (1. Sci. Pharm., Kitasato Univ., 2. Pharm. Dept., Kitasato Univ. Hosp.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.